Skip to main content
. Author manuscript; available in PMC: 2015 Oct 21.
Published in final edited form as: Clin Pharmacol Ther. 2008 May 28;85(2):155–163. doi: 10.1038/clpt.2008.95

Figure 3.

Figure 3

Association of the CYP3A4/5*2 haplotype with (a) midazolam clearance and (b) erythromycin breath test concentration at 20 min (ERMBT C20). Each symbol represents an individual patient, and horizontal lines indicate median values. The black triangles in the group of noncarriers represent CYP3A5 expressors.